Why Do the Principals of Cardeation Capital Think Joining Forces Makes Sense for Innovation?
Click the link below to listen: Medtech Talk Podcast hosted by Tom…
Over the past decade Medicare has spent more than $1.5 billion to replace defective heart devices for 73,000 patients. That’s according to a report from the Health and Human Services (HHS) Office of Inspector General (OIG). The OIG is an organization mandated to protect the integrity of HHS programs, including Medicare and the U.S. Food and Drug Administration (FDA).
Some of the costs for removing faulty heart devices has also fallen to consumers, however. Out-of-pocket expenses related to device recalls totaled $140 million during the same period, according to the report.
Continue reading at: https://www.healthline.com/health-news/faulty-heart-devices-costly-for-medicare
Click the link below to listen: Medtech Talk Podcast hosted by Tom…
DALLAS, April 9, 2018 /PRNewswire-USNewswire/ -- Patients battling cardiovascular diseases, and even people hoping…
Livongo Joins American Heart Association’s Center for Health Technology and Innovation to…
GoMo Health is excited to announce that we are joining the American…